Meet the fastGEN technology

BioVendor developed user friendly diagnostic NGS kits with excellent analytical parameters and extremely fast processing for laboratories of any size.
Meet the fastGEN technology

Personalised therapy can provide an opportunity for patients with various types of cancer to prolong and improve their quality of life. To effectively set up the therapy, it is necessary to distinguish patients who will benefit from treatment from patients whose cancer is naturally resistant to the therapy. The appropriate predictive molecular markers can increase the overall effectiveness and reduce the financial costs of the therapy.

Knowledge about the mutation status of KRAS, NRAS, BRAF, EGFR and IDH 1/2 genes is required to indicate the proper treatment of metastatic carcinomas and to assess the disease prognosis.

Single technology, mutliple opportunities

BioVendor brings new technology fastGEN for examination of the mutation status of oncomarkers in samples. Technology is base on ultra-deep sequencing of short amplicons obtained by a single polymerase chain reaction with special tagged hybrid primers.

The fastGEN technology is simple, ultra-sensitive, specific and effective - it is perfectly adapted to diagnostics. With ready-to-use reagents, a user-friendly workflow and all-in-one solution for the analysis of raw data offers fastGEN technology new advantages for clinical material.

End-to-end solution combining library preparation with bioinformatic analysis

The procedure is designed to allow parallel processing of samples for KRAS, NRAS, BRAF, EGFR and IDH 1/2 genes. FastGEN technology reduces hands-on time and minimizes the risk of contamination.

For raw data analysis (FASTQ files) we brings software GENOVESA module fastGEN with technical and application support provided in the English language.

More about diagnostic NGS kits

You might also be interested in

miR-129-5p as a promising biomarker in obesity research

miR-129-5p as a promising biomarker in obesity research

The epidemic of obesity is now recognised as one of the most important public health problems facing the world today.
Discover more
Circulating Biomarkers in Critical Illness and Sepsis

Circulating Biomarkers in Critical Illness and Sepsis

Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its tissues and organs.
Discover more

Stay informed

For current information, follow our profiles on social media.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.